• OPEN AN ACCOUNT
Indian Indices
Sensex
74,729.27 413.66
( 0.56%)
Global Indices
Nasdaq
52,191.76 549.28
(1.06%)
Dow Jones
7,764.37 24.43
(0.32%)
Hang Seng
65,489.63 1,063.68
(1.65%)
Nikkei 225
10,840.19 115.33
(1.08%)
Forex
USD-INR
95.08 -0.14
(-0.15%)
EUR-INR
106.23 -0.27
(-0.26%)
GBP-INR
125.74 -0.30
(-0.24%)
JPY-INR
0.60 0.00
(-0.23%)

EQUITY - MARKET SCREENER

Albert David Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
524075
INE155C01010
685.7077058
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
ALBERTDAVD
19.95
450.09
EPS(TTM)
Face Value()
Div & Yield %
39.52
10
0.63
 

Albert David reports standalone net loss of Rs 21.43 crore in the March 2026 quarter
May 13,2026
Net Loss of Albert David reported to Rs 21.43 crore in the quarter ended March 2026 as against net loss of Rs 10.33 crore during the previous quarter ended March 2025. Sales rose 14.65% to Rs 85.86 crore in the quarter ended March 2026 as against Rs 74.89 crore during the previous quarter ended March 2025.

For the full year,net loss reported to Rs 1.49 crore in the year ended March 2026 as against net profit of Rs 17.20 crore during the previous year ended March 2025. Sales declined 3.52% to Rs 333.60 crore in the year ended March 2026 as against Rs 345.77 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales85.8674.89 15 333.60345.77 -4
OPM %3.21-6.34 -1.640.87 -
PBDT-22.51-9.99 -125 10.2832.19 -68
PBT-25.23-11.81 -114 0.5225.22 -98
NP-21.43-10.33 -107 -1.4917.20 PL